Alnylam Pharmaceuticals | Операционный Доход


Operating Profit Изменить
Acadia Pharmaceuticals ACAD:US $ -113.02M 68.36M
Agios Pharmaceuticals AGIO:US $ -98.44M 3.74M
Alnylam Pharmaceuticals ALNY:US $ -146.73M 47.83M
Amgen AMGN:US $ 2500M 196M
Arrowhead Research ARWR:US $ 41.55M 104.87M
Avrobio Inc AVRO:US -29418000 1.46M
Biocryst Pharmaceuticals BCRX:US $ -49.96M 53.62M
Biomarin Pharmaceutical BMRN:US $ 137.33M 203.21M
Bluebird Bio BLUE:US $ -120.35M 15.32M
Intercept Pharmaceuticals ICPT:US $ -10.27M 10.59M
IONIS PHARMACEUT IONS:US $ -57.5M 278.11M
Mirati Therapeutics MRTX:US $ -184.22M 12.86M
Moderna Inc MRNA:US 4.23B 1.18B
Neurocrine Biosciences NBIX:US $ 3.1M 39.4M
Novartis NVS:US $ 2852M 290M
Ptc Therapeutics PTCT:US $ -86.52M 1.79M
Regeneron Pharmaceuticals REGN:US $ 1258.5M 1381.2M
Regulus Therapeutics RGLS:US $ -6.57M 0.39M
Sangamo Biosciences SGMO:US $ -45.26M 5.36M
Sarepta Therapeutics SRPT:US $ -86.88M 18.93M
Takeda 4502:JP Y -1619M 118103M
Ultragenyx Pharmaceutical RARE:US $ -136.63M 34.07M
Vertex Pharmaceuticals VRTX:US $ 1040.9M 163.18M
Xencor XNCR:US $ 26.47M 65.39M
YTE INCY:US $ 116.54M 5.81M



Alnylam Pharmaceuticals Операционный Доход - Текущие значения, предыдущие значения, прогнозы, графики и экономический календарь - Jul 2022.